Coloplast A/S (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S (OTCMKTS:CLPBY) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 280,600 shares, a growth of 264.4% from the February 28th total of 77,000 shares. Based on an average trading volume of 482,700 shares, the days-to-cover ratio is currently 0.6 days.

Coloplast A/S Stock Performance

Shares of OTCMKTS:CLPBY opened at $10.52 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92. Coloplast A/S has a 1-year low of $10.31 and a 1-year high of $14.14. The firm has a fifty day moving average price of $10.99 and a 200 day moving average price of $11.90.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a net margin of 17.81% and a return on equity of 28.60%. On average, equities analysts anticipate that Coloplast A/S will post 0.31 EPS for the current fiscal year.

Analyst Ratings Changes

CLPBY has been the topic of several research analyst reports. UBS Group upgraded shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 11th. Sanford C. Bernstein upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, Royal Bank of Canada upgraded shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.